Consainsights logo
Reports / Hemophilia Market

Hemophilia Market

Hemophilia Market Research Report – Segmented By Disease Type (Hemophilia A, Hemophilia B, Others), Therapy (Gene Therapy, Others (Immune Tolerance Induction Therapy etc.), Replacement Therapy), Product Type (Others (Desmopressin etc.), Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Hemophilia Market was valued at US $13.82 billion in 2021 and is projected to grow at 7.96% CAGR over the forecast period to reach US $21.89 billion by 2027. Hemophilia Market represented US $1.96 billion opportunity over 2019-2021 and estimated to create US $8.07 billion opportunity in 2027 over 2021.

Hemophilia from Consainsights analyses the Hemophilia Market in the Life Sciences industry over the forecast period to 2027.

Hemophilia research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Hemophilia segmentation includes Disease Type, Therapy, Product Type and Geography.

Based on the Disease Type, the Hemophilia analysis covers Hemophilia A, Hemophilia B, Others.

In Disease Type segment, Hemophilia A segment has highest cagr growth of 7.05%.

Based on the Therapy, the Hemophilia analysis covers Replacement Therapy, Gene Therapy, Others (Immune Tolerance Induction Therapy etc.).

In Therapy segment, Replacement Therapy segment has highest cagr growth of 7.05%.

Based on the Product Type, the Hemophilia analysis covers Recombinant Coagulation Factor Concentrates, Plasma-derived Coagulation Factor Concentrates, Others (Desmopressin etc.).

In Product Type segment, Recombinant Coagulation Factor Concentrates segment has highest cagr growth of 7.05%.

Based on the region, the Hemophilia analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Bayer AG, BioMarin Pharmaceutical, Inc., CSL Behring, Kedrion S.p.A, Novo Nordisk, Pfizer, Inc., Roche (Chugai Pharmaceutical Co.), Sanofi (Genzyme Corporation), Takeda Pharmaceutical (Shire Plc.), Genentech, Grifols, Medexus, Octapharma and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Disease Type (2021)
    Revenue Share (%), By Disease Type (2021)
  • Revenue Share (%), By Therapy (2021)
    Revenue Share (%), By Therapy (2021)
  • Revenue Share (%), By Product Type (2021)
    Revenue Share (%), By Product Type (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Disease Type

  • Hemophilia A accounted for US$7.53 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Hemophilia B accounted for US$2.26 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Others accounted for US$4.03 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Hemophilia Market Y-o-Y Growth (USD billion), By Disease Type 2019 - 2027
Hemophilia Market Y-o-Y Growth (USD billion), By Disease Type 2019 - 2027
Hemophilia Market Size, By Disease Type, 2019-2027 (USD billion)
Hemophilia Market Size, By Disease Type, 2019-2027 (USD billion)

The Hemophilia A segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hemophilia A: global Hemophilia Market Revenue Opportunity (Us$ Mn)
Hemophilia A: global Hemophilia Market Revenue Opportunity (Us$ Mn)

The Hemophilia B segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hemophilia B: global Hemophilia Market Revenue Opportunity (Us$ Mn)
Hemophilia B: global Hemophilia Market Revenue Opportunity (Us$ Mn)

The Others segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Others: global Hemophilia Market Revenue Opportunity (Us$ Mn)
Others: global Hemophilia Market Revenue Opportunity (Us$ Mn)
04

By Therapy

  • Replacement Therapy accounted for US$5.55 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Gene Therapy accounted for US$5.27 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Others (Immune Tolerance Induction Therapy etc.) accounted for US$2.99 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Hemophilia Market Y-o-Y Growth (USD billion), By Therapy 2019 - 2027
Hemophilia Market Y-o-Y Growth (USD billion), By Therapy 2019 - 2027
Hemophilia Market Size, By Therapy, 2019-2027 (USD billion)
Hemophilia Market Size, By Therapy, 2019-2027 (USD billion)

The Gene Therapy segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Gene Therapy: global Hemophilia Market Revenue Opportunity (Us$ Mn)
Gene Therapy: global Hemophilia Market Revenue Opportunity (Us$ Mn)

The Others (Immune Tolerance Induction Therapy etc.) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Others (Immune Tolerance Induction Therapy etc.): global Hemophilia Market Revenue Opportunity (Us$ Mn)
Others (Immune Tolerance Induction Therapy etc.): global Hemophilia Market Revenue Opportunity (Us$ Mn)

The Replacement Therapy segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Replacement Therapy: global Hemophilia Market Revenue Opportunity (Us$ Mn)
Replacement Therapy: global Hemophilia Market Revenue Opportunity (Us$ Mn)
05

By Product Type

  • Recombinant Coagulation Factor Concentrates accounted for US$6.06 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Plasma-derived Coagulation Factor Concentrates accounted for US$4.72 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Others (Desmopressin etc.) accounted for US$3.04 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Hemophilia Market Y-o-Y Growth (USD billion), By Product Type 2019 - 2027
Hemophilia Market Y-o-Y Growth (USD billion), By Product Type 2019 - 2027
Hemophilia Market Size, By Product Type, 2019-2027 (USD billion)
Hemophilia Market Size, By Product Type, 2019-2027 (USD billion)

The Others (Desmopressin etc.) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Others (Desmopressin etc.): global Hemophilia Market Revenue Opportunity (Us$ Mn)
Others (Desmopressin etc.): global Hemophilia Market Revenue Opportunity (Us$ Mn)

The Plasma-derived Coagulation Factor Concentrates segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Plasma-derived Coagulation Factor Concentrates: global Hemophilia Market Revenue Opportunity (Us$ Mn)
Plasma-derived Coagulation Factor Concentrates: global Hemophilia Market Revenue Opportunity (Us$ Mn)

The Recombinant Coagulation Factor Concentrates segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Recombinant Coagulation Factor Concentrates: global Hemophilia Market Revenue Opportunity (Us$ Mn)
Recombinant Coagulation Factor Concentrates: global Hemophilia Market Revenue Opportunity (Us$ Mn)
06

North America

  • In 2021, North America segment accounted for US$13.82 Bn and is expected grow with a CAGR of 7.96% over the forecast years.
  • In North America, United States accounted for US$7.12 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$6.70 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Hemophilia Market, By Country, 2019-2027 (USD billion)
North America Hemophilia Market, By Country, 2019-2027 (USD billion)
North America Hemophilia Market - Market Opportunity (USD billion), 2019, 2021 & 2027
North America Hemophilia Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Disease Type - North America (2021)
Revenue Share (%), By Disease Type - North America (2021)
Revenue Share (%), By Therapy - North America (2021)
Revenue Share (%), By Therapy - North America (2021)
Revenue Share (%), By Product Type - North America (2021)
Revenue Share (%), By Product Type - North America (2021)
North America Hemophilia Market, By Country, 2019-2027 (USD billion)
North America Hemophilia Market, By Country, 2019-2027 (USD billion)
United States Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
United States Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
United States Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
United States Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
United States Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United States Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Canada Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Canada Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Canada Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Canada Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Canada Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Canada Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
07

Europe

  • In 2021, Europe segment accounted for US$13.82 Bn and is expected grow with a CAGR of 7.96% over the forecast years.
  • In Europe, Germany accounted for US$5.26 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$3.23 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$2.10 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$1.50 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$0.79 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$0.48 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$0.45 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Hemophilia Market, By Country, 2019-2027 (USD billion)
Europe Hemophilia Market, By Country, 2019-2027 (USD billion)
Europe Hemophilia Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Europe Hemophilia Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Disease Type - Europe (2021)
Revenue Share (%), By Disease Type - Europe (2021)
Revenue Share (%), By Therapy - Europe (2021)
Revenue Share (%), By Therapy - Europe (2021)
Revenue Share (%), By Product Type - Europe (2021)
Revenue Share (%), By Product Type - Europe (2021)
Europe Hemophilia Market, By Country, 2019-2027 (USD billion)
Europe Hemophilia Market, By Country, 2019-2027 (USD billion)
Germany Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Germany Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Germany Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Germany Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Germany Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Germany Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United Kingdom Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
United Kingdom Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
United Kingdom Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
United Kingdom Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
United Kingdom Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
United Kingdom Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
France Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
France Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
France Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
France Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
France Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
France Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Spain Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Spain Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Spain Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Spain Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Spain Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Spain Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Russia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Russia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Russia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Russia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Russia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Russia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Italy Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Italy Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Italy Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Italy Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Italy Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Italy Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Europe Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Rest of Europe Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Rest of Europe Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Rest of Europe Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Rest of Europe Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Europe Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
08

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$13.82 Bn and is expected grow with a CAGR of 7.96% over the forecast years.
  • In Asia-Pacific, China accounted for US$5.28 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$3.58 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$2.34 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$1.19 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$1.09 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$0.33 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Hemophilia Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Hemophilia Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Hemophilia Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Asia-Pacific Hemophilia Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Disease Type - Asia-Pacific (2021)
Revenue Share (%), By Disease Type - Asia-Pacific (2021)
Revenue Share (%), By Therapy - Asia-Pacific (2021)
Revenue Share (%), By Therapy - Asia-Pacific (2021)
Revenue Share (%), By Product Type - Asia-Pacific (2021)
Revenue Share (%), By Product Type - Asia-Pacific (2021)
Asia-Pacific Hemophilia Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Hemophilia Market, By Country, 2019-2027 (USD billion)
China Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
China Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
China Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
China Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
China Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
China Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Japan Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Japan Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Japan Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Japan Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Japan Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Japan Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
India Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
India Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
India Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
India Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
India Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
India Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Southeast Asia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Southeast Asia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Southeast Asia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Southeast Asia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Southeast Asia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Southeast Asia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Australia & New Zealand Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Australia & New Zealand Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Australia & New Zealand Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Australia & New Zealand Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Australia & New Zealand Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Australia & New Zealand Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Asia-Pacific Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Rest of Asia-Pacific Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Rest of Asia-Pacific Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Rest of Asia-Pacific Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Rest of Asia-Pacific Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Asia-Pacific Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
09

Middle East & Africa

Based on the Middle East & Africa, the Hemophilia Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Hemophilia Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Hemophilia Size, 2019-2027 (Us$ Mn)
Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Middle East Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Middle East Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Middle East Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Middle East Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Middle East Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Middle East Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Rest of Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Rest of Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Rest of Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Rest of Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Middle East & Africa Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
10

Latin America

  • In 2021, Latin America segment accounted for US$13.82 Bn and is expected grow with a CAGR of 7.96% over the forecast years.
  • In Latin America, Brazil accounted for US$6.07 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$3.72 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$2.08 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$1.55 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$0.39 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Hemophilia Market, By Country, 2019-2027 (USD billion)
Latin America Hemophilia Market, By Country, 2019-2027 (USD billion)
Latin America Hemophilia Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Latin America Hemophilia Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Disease Type - Latin America (2021)
Revenue Share (%), By Disease Type - Latin America (2021)
Revenue Share (%), By Therapy - Latin America (2021)
Revenue Share (%), By Therapy - Latin America (2021)
Revenue Share (%), By Product Type - Latin America (2021)
Revenue Share (%), By Product Type - Latin America (2021)
Latin America Hemophilia Market, By Country, 2019-2027 (USD billion)
Latin America Hemophilia Market, By Country, 2019-2027 (USD billion)
Brazil Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Brazil Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Brazil Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Brazil Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Brazil Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Brazil Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Argentina Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Argentina Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Argentina Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Argentina Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Argentina Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Argentina Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Mexico Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Mexico Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Mexico Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Mexico Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Mexico Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Mexico Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Colombia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Colombia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Colombia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Colombia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Colombia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Colombia Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Latin America Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Rest of Latin America Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Disease Type, 2019-2027
Rest of Latin America Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Rest of Latin America Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Therapy, 2019-2027
Rest of Latin America Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
Rest of Latin America Hemophilia Market - Historical, Forecast Market Sizes (US$ MN), By Product Type, 2019-2027
11

Company Analysis

  • Bayer AG
  • BioMarin Pharmaceutical, Inc.
  • CSL Behring
  • Kedrion S.p.A
  • Novo Nordisk
  • Pfizer, Inc.
  • Roche (Chugai Pharmaceutical Co.)
  • Sanofi (Genzyme Corporation)
  • Takeda Pharmaceutical (Shire Plc.)
  • Genentech
  • Grifols
  • Medexus
  • Octapharma